Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Palo Alto, California
- Most recent report
- 10-Q, filed Jul 30, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1576280
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 82
Prospectuses and Registrations 8 of 19
- S-3ASR Automatic shelf registration Jul 30, 2026
- S-8 Registration statement for an employee plan Feb 20, 2026
- 424B5 Prospectus supplement for an offering Nov 6, 2025
- FWP Free writing prospectus Nov 5, 2025
- FWP Free writing prospectus Nov 4, 2025
- 424B5 Prospectus supplement for an offering Nov 4, 2025
- S-8 Registration statement for an employee plan Feb 24, 2025
- 424B5 Prospectus supplement for an offering Aug 23, 2024
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEFA14A Extra proxy material Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 856
- 144 Notice of a proposed sale of restricted stock Oct 16, 2026
- 4 Insider reported a trade Oct 15, 2026
- 144 Notice of a proposed sale of restricted stock Oct 14, 2026
- 4 Insider reported a trade Oct 13, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Oct 2, 2026
Other 7
Everything here comes from Guardant Health, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.